First Time Loading...

Cerevel Therapeutics Holdings Inc
NASDAQ:CERE

Watchlist Manager
Cerevel Therapeutics Holdings Inc Logo
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Watchlist
Price: 42.145 USD -0.48% Market Closed
Updated: May 17, 2024

EV/S
Enterprise Value to Sales

0
Current
0
Median
7.4
Industry
Higher than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
0
=
Enterprise Value
7.2B
/
Revenue
0
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
N/A
2-Years Forward
EV/S
N/A
3-Years Forward
EV/S
115.6

See Also

Discover More